Investorideas.com - World's First #THC-Infused Alcohol Removed #Wine From Rebel Coast Winery Features ebbu's Cutting-Edge HydroPS Cannabinoid Tech
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Thursday, August 9, 2018
Investorideas.com - 13 New U.S. #Cannabis Markets Could Push Legal Revenues Above $30 Billion by 2025
Investorideas.com - 13 New U.S. #Cannabis Markets Could Push Legal Revenues Above $30 Billion by 2025
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $WEED.TO, NYSE: $CGC, NADSAQ: $CRON, TSX: $CRON.TO, CSE: $THC.C, CSE: $CRZ.C
Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: TSX: $WEED.TO,
NYSE: $CGC, NADSAQ: $CRON, TSX: $CRON.TO, CSE: $THC.C, CSE: $CRZ.C
Delta, Kelowna, BC - August 9, 2018 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s
edition of its series, Investorideas.com
potcastsCM - cannabis news and stocks to watch plus insight from
thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/08091Potcasts-TSX-WEED-NYSE-CGC-NASDAQ-CRON-CSE-THC-CRZ.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from THC BioMed Intl Ltd
trading on the CSE as THC, CannaRoyalty
Corp. trading on the CSE as CRZ, Canopy Growth Corporation trading on
the TSX as WEED and the NYSE as CGC and Cronos Group Inc. trading on the NASDAQ
and the TSX as CRON.
THC BioMed Intl Ltd announced that it has developed a cannabis beverage
that mimics alcohol in that the uplifting and energizing effects of the
cannabis is felt by the consumer in a short period of time. THC believes that
this beverage is a solution to a major problem with cannabis beverages and
edibles, as current products cause fatigue and drowsiness.
John Miller CEO comments "THC has conducted extensive research on
cannabis edibles and beverages and I have found our product to be exclusive in
its category. Our product is absolutely unique in contrast to other products in
the industry that simply cannot deliver the expected experience, especially if
you are a frequent cannabis user. We are thrilled to have formulated a cannabis
beverage that is purely organic, works in a recreational setting and can offer
even the most seasoned consumers an entirely new and invigorating
experience."
Furthermore, it is the first cannabis beverage known to THC that
delivers both mental and body highs through ingestion. THC intends to patent
this formula and the Company is confident its beverage, to be named "THC
KISS", when legally allowed, will bring a fresh experience to the adult
use recreational cannabis market.
Although production and sale of the beverage is not currently legal in
Canada, it may become legal at a later date.
CannaRoyalty Corp., a leading North American
cannabis products and brands company, today announced the close of the previously
announced acquisition of its investee company Anandia Laboratories Inc. by
Aurora Cannabis Inc. for approximately $115 million.
Under CannaRoyalty's formerly disclosed investment relationship with
Anandia, CannaRoyalty initially invested approximately $4 million in Anandia,
in February 2017. With the close of the Acquisition, CannaRoyalty's equity
stake in Anandia is valued at approximately $17 million based on the closing
price of Aurora shares on August 8, 20181, representing a return on
investment of approximately 315% for the Company's shareholders.
Canopy Growth Corporation announced the acquisition of all remaining
outstanding shares of its Chilean in-market entity, Spectrum Cannabis Chile
SpA.
This transaction brings Spectrum Cannabis Chile fully under the
Canopy Growth umbrella and directly supports the Company's plans for
development within the LATAM region which is home to more than 600 million
people. Thanks to progressive regulations and Government support, Chile is
known throughout Latin America as an ideal location for medical and
pharmaceutical research. The country has more clinical studies per resident
than any other in Latin America.
In line with the Company's strategy of leveraging the strengths of each
country, Chile will continue as Canopy LATAM's regional research and
development hub. Currently, Spectrum Cannabis Chile has a pain management
focused clinical trial underway. The trial which has been approved at both
Phase I and Phase II was designed by Dr. Serio Sánchez, a Chilean doctor,
medical cannabis pioneer, and the founder of Cannabis Chile, one of the
country's leading cannabis advocacy groups.
In addition to advancing this clinical trial, Dr. Sánchez has joined the
leadership team of Spectrum Cannabis Chile and will bring his extensive
experience to the organization by serving as the Chilean medical lead. He will
also serve on the Medical Board for Canopy LATAM, the company's regional
headquarters. Having treated over 5000 patients with medical cannabis, Dr.
Sánchez has a wealth of experience in evaluating and advancing the recognition
as well as use of cannabis-based medicines.
Cronos Group Inc. announced that it has entered into a supply agreement
with one of the largest cannabis companies in the world by revenue in the first
quarter of 2018, Cura Select Canada, Ltd. Cura is on a mission to be the
leading provider of premium cannabis oil and hemp oil to the legal U.S. and
international markets, and will enter the Canadian market to supply domestic
and international channels through this agreement.
The Company has signed a five-year take-or-pay supply agreement to
purchase a minimum of 20,000 kilograms of cannabis per annum from Cronos
Growing Company Inc. Cura expects to build its proprietary, state-of-the-art
extraction facility on a parcel of land owned by Original BC ("OGBC")
in the heart of Okanagan Valley, British Columbia. Given the commitment that
both companies have to providing consumers with the best product quality,
Cronos will be selecting and cultivating ideal strains for Cura's extraction
methodology. The new facility is intended to serve as Cura's hub for the
Canadian and international market.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, iHeartradio and
Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Wednesday, August 8, 2018
Investorideas.com - Northern Mariana Islands House of Representatives Approves Bill to Legalize and Regulate Marijuana for Adult and Medical Use; Measure Now Heads to the Senate
Investorideas.com - Northern Mariana Islands House of Representatives Approves Bill to Legalize and Regulate Marijuana for Adult and Medical Use; Measure Now Heads to the Senate
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $APH.TO, TSX: $ACB.TO, TSX: $CLIQ.TO, TSX: $WEED.TO, TSX: $TRST.TO, CSE: $MTEC.C, CSE: $MYM.C
Investor Ideas #Potcasts #Cannabis
News and #Stocks on the Move: TSX: $APH.TO, TSX: $ACB.TO, TSX: $CLIQ.TO, TSX: $WEED.TO,
TSX: $TRST.TO, CSE: $MTEC.C, CSE: $MYM.C
Delta, Kelowna, BC – August 8, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/08082Potcasts-TSX-APH-ACB-CLIQ-WEED-TRST-CSE-MTEC-MYM.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from Aphria Inc. trading on
the TSX as APH and US OTC as APHQF, Aurora Cannabis Inc.
trading on the TSX as ACB and the OTCQB as ACBFF, Alcanna Inc. trading on the
TSX as CLIQ, Canopy Growth Corporation trading on the TSX as WEED and the NYSE
as CGC, CannTrust Holdings Inc. trading on the TSX as TRST,
Cannvas MedTech Inc. trading on the CSE as
MTEC and MYM Nutraceuticals Inc., trading on the CSE as MYM and the OTC as MYMMF.
Aphria Inc. today announced that it has signed a Manufacturer's
Representative agreement with We Grow BC Ltd., a Vancouver-based licensed
producer of premium cannabis, to become We Grow's exclusive sales
representative across Canada. The Agreement adds a second brand of premium
B.C.-bud to be sold alongside Aphria's expanding portfolio of adult-use brands,
which includes celebrated B.C.-bud from Broken Coast Cannabis, through the
Company's coast-to-coast sales distribution network.
"Aphria has an unmatched ability to offer a cross-Canada sales and
distribution network for adult-use cannabis," said Jakob Ripshtein, Chief
Commercial Officer at Aphria. "We are pleased to complement our existing,
and soon-to-be unveiled, in-house adult-use brands with an expanding portfolio
of partner brands like We Grow. With our well-established relationships and an
extensive network of distribution facilities and resources, we are confident
that all our brands, and those of our partners, will be proudly represented in
stores and online throughout the country."
Aphria's sales team is supported by Great North Distributors, a
subsidiary of Southern Glazer's Wine & Spirits, which was previously
announced as Aphria's exclusive cannabis representative in Canada, providing
the Company with 100% coverage of all cannabis retailers, whether provincially
or privately operated, from the first day of legal adult-use sales.
Aurora Cannabis Inc. and Alcanna Inc. today announced that the companies
have reached a license agreement whereby Alcanna has been given
exclusive rights to open retail cannabis stores under the brand name
"Aurora" across Canada. Alcanna's position as the biggest private
sector liquor retailer in Canada, aligns with Aurora's position as one of the
world's leading cannabis companies.
In February, Aurora announced its strategic investment in Alcanna
(formerly Liquor Stores NA), the Edmonton, Alberta-based retailer of alcoholic
beverages with 229 retail outlets in Western Canada and Alaska, with a view to
establishing a leading brand of cannabis retail outlets. This forward-thinking
partnership combines Aurora's brand leadership, high-quality products, customer
care and scientific innovations with Alcanna's well-established retailing
infrastructure and expertise. Over the last 25 years, Alcanna has established
an exemplary track-record of responsibly retailing controlled substances in
retail environments that require strict compliance with government regulations.
The stores will operate under the "Aurora" banner, but will
represent a house of brands, carrying a carefully curated, but broad selection
of products from Licensed Producers across Canada, including Aurora, MedReleaf
and CanniMed.
Canopy Growth Corporation and its wholly owned subsidiary, Canopy Health
Innovations Inc. announced that approval has been received from the Veterinary
Drug Directorate of Health Canada to research the effectiveness of cannabidiol
("CBD") to treat anxiety in certain animals. The research will be
conducted by Canopy Animal Health ("CAH"), a division of Canopy
Health which focuses on developing cannabis-based healthcare products for
companion animals.
The approval comes in the form of a No Objection Letter for the use of a
proprietary CBD enriched oil formulation, previously administered in
preclinical dosing and safety studies, as a potential therapy for anxiety. The CBD
formulation will be produced by Canopy Growth in its GMP-certified production
facility in Smiths Falls, Ontario.
Canopy Animal Health, the global leader in cannabinoid science for pets,
continues to build a strong portfolio of safety and dosing data for certain
animals which it plans to share with the veterinary community and pet owners,
through publications and scientific conferences.
CannTrust Holdings Inc., one of Canada's leading licensed producers and
most trusted brands of cannabis announced today that the Company is
accelerating its exclusive partnership with Apotex Inc., the largest
Canadian-owned generic pharmaceutical company and a global leader and innovator
in the production and distribution of high-quality, affordable medicines. Ahead
of schedule, the partnership is developing alternate dosage formats for medical
cannabis products, which will advance CannTrust's leadership in the medical
cannabis market in Canada, and on a global basis. The Companies are increasing
their focus on extensive research and development. The result will be
innovative new products and competitive additions to the CannTrust portfolio,
including both quick release and sustained release formats for THC and CBD.
This advancement will provide more choice to meet the growing demand from both
healthcare practitioners and their patients for standardized cannabis
dosages.
Cannvas MedTech Inc., a leading business
technology company in the cannabis space, is pleased to announce the completion
of it's Machine Learning integration milestone within the CANNVAS.ME platform,
set to launch summer 2018..
"This is a significant achievement for our development team here at
Cannvas," said Radu Puscasu, Vice President of Technology, Cannvas MedTech
Inc. "Our mission to provide education without outside influences is
further enhanced as we implement true user-driven site interaction
technologies. We look forward to achieving additional milestones as we continue
to push the technology boundaries for the Cannvas.me platform."
As customers engage with the online Cannvas.me platform and interactions
continue to increase, our Machine Learning technology is also learning from
each interaction. Utilizing this proprietary form of artificial intelligence,
the education platform is able to learn from user's interactions
and engagement behaviour in a continuous fashion. The intelligent use of
this data allows for a highly relevant and immersive user experience that is
based on each individual's unique set of behavioural data. This allows Cannvas.me
to serve personalized content and educational materials from its Cannvas
Academy that are tailored to the individual’s cannabis journey of education.
MYM Nutraceuticals Inc., announced that it has entered into an agreement
with Amsterdam-based Dutch Passion Seed Company for the production and
distribution of Dutch Passion branded products and seed genetics in Colombia.
This follows the August 1 announcement of a similar agreement between Dutch
Passion and MYM for production and distribution of branded products and seed
genetics in Australia.
Established in 1987, Dutch Passion is the second-oldest European
Cannabis seed company and for over 30 years has been a leading innovator of
seed genetics. Dutch Passion has developed its own proprietary genetics and owns
a seed collection of international cannabis genetics dating back to the 1970s.
The company has won more than 50 Cannabis Cups for its high-THC, easy-to-grow
varieties. Dutch Passion also invented feminized cannabis seeds in the 1990s
and, more recently, helped pioneer the success of high-THC auto-flowering
cannabis seeds.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, iHeartradio and
Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Subscribe to:
Posts (Atom)